Matches in Wikidata for { <http://www.wikidata.org/entity/Q92136458> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q92136458 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92136458 description "scientific article published on 16 May 2019" @default.
- Q92136458 description "wetenschappelijk artikel" @default.
- Q92136458 description "наукова стаття, опублікована 16 травня 2019" @default.
- Q92136458 name "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 name "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 type Item @default.
- Q92136458 label "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 label "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 prefLabel "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 prefLabel "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 P1433 Q92136458-1618A866-6FAC-4C6B-AAFD-E17A46360ECB @default.
- Q92136458 P1476 Q92136458-18C45B47-8B20-46E0-984B-1AB16B68FC6A @default.
- Q92136458 P2093 Q92136458-10B0B9CC-5DDA-4622-90B4-559000DB0D12 @default.
- Q92136458 P2093 Q92136458-2DA202A2-AE4E-4117-93D0-476FA711F842 @default.
- Q92136458 P2093 Q92136458-3549AC4A-5717-44FD-940C-0208D699CA0A @default.
- Q92136458 P2093 Q92136458-44B4D989-9B68-4259-A764-898F035C0018 @default.
- Q92136458 P2093 Q92136458-C6B3C402-4476-4F3D-BF41-00EC6119BB0A @default.
- Q92136458 P304 Q92136458-60775C56-BDFE-457F-8A6A-BA2CED55A3C8 @default.
- Q92136458 P31 Q92136458-D5F0DA43-C599-4BDA-AC7F-D0267A1BEE32 @default.
- Q92136458 P356 Q92136458-626FBF7D-7FE6-422F-B96A-C95F65785D4B @default.
- Q92136458 P478 Q92136458-68611014-811E-44AC-9FD6-A920E4FBCDC6 @default.
- Q92136458 P577 Q92136458-48A7A139-FD51-45C7-9156-BDEBE82D4BD3 @default.
- Q92136458 P698 Q92136458-4AD13069-55ED-4904-BFB4-AA51153ED4DF @default.
- Q92136458 P921 Q92136458-3F0AAFB8-E0B8-4C47-8B3A-492414177C0E @default.
- Q92136458 P356 J.NANO.2019.04.016 @default.
- Q92136458 P698 31103736 @default.
- Q92136458 P1433 Q6964073 @default.
- Q92136458 P1476 "Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma" @default.
- Q92136458 P2093 "Hossein Attar" @default.
- Q92136458 P2093 "Mahmoud Reza Jaafari" @default.
- Q92136458 P2093 "Mitra Korani" @default.
- Q92136458 P2093 "Mohammad Mashreghi" @default.
- Q92136458 P2093 "Solmaz Ghaffari" @default.
- Q92136458 P304 "102013" @default.
- Q92136458 P31 Q13442814 @default.
- Q92136458 P356 "10.1016/J.NANO.2019.04.016" @default.
- Q92136458 P478 "20" @default.
- Q92136458 P577 "2019-05-16T00:00:00Z" @default.
- Q92136458 P698 "31103736" @default.
- Q92136458 P921 Q18554829 @default.